ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Blind at birth: Pioneering gene therapy restores vision to victims of rare retinal blindness – Genetic Literacy Project

Continue reading

2017-08-07 Michael Zand NEWS

Gene therapy skin grafts for obesity and diabetes – BioNews


Genetic Literacy Project

Blind at birth: Pioneering gene therapy restores vision to victims of rare retinal blindness
Genetic Literacy Project
Three years ago, at a fundraiser near Philadelphia for the Curing Retinal Blindness Foundation, I stood, dumbstruck, as young teen Christian Guardino took the stage and belted out Don’t Stop Believing. Christian had recently undergone gene therapy that …

Continue reading

2017-08-07 Michael Zand NEWS

Scientists Discover Dozens of New Genes that Create T-Cell Resistant Cancer – NYU News (press release)


TheHealthSite

Gene therapy skin grafts for obesity and diabetes
BioNews
A proof-of-concept study in mice has demonstrated how skin grafts could deliver gene therapy for obesity and diabetes. ‘We think this platform has the potential to lead to safe and durable gene therapy, in mice and we hope, someday, in humans, using …
New gene therapy through skin transplants can help improve …TheHealthSite
Gene therapy via skin may treat diabetes, obesityThe Statesman
Gene therapy via skin may treat diabetes, obesity – appsforpcdaily.comAppsforPCdaily
domain-B –Tech Times
all 9 news articles »
Continue reading

2017-08-07 Michael Zand NEWS

Durable Immunotherapy Benefits Foster Excitement in Bladder Cancer, Despite Low Response Rates – Targeted Oncology

Scientists Discover Dozens of New Genes that Create T-Cell Resistant Cancer
NYU News (press release)
“We cast a wide, deep net and conducted an unbiased survey of all of the 19,000 genes in the cancer’s genome – not just the genes that are known to be involved in creating immunotherapy-resistant tumors,” explains the study’s senior author, Nicholas P.

Continue reading

2017-08-07 Michael Zand NEWS

NCI study identifies essential genes for cancer immunotherapy – National Institutes of Health (press release)


Targeted Oncology

Durable Immunotherapy Benefits Foster Excitement in Bladder Cancer, Despite Low Response Rates
Targeted Oncology
While immunotherapy agents have only demonstrated a clinical benefit for approximately 15% to 20% of patients with urothelial carcinoma, it’s the durable responses observed in these patients that have doctors excited, says Arlene Siefker-Radtke, MD.

Continue reading

2017-08-07 Michael Zand NEWS

NCI study identifies essential genes for cancer immunotherapy – EurekAlert (press release)

NCI study identifies essential genes for cancer immunotherapy
National Institutes of Health (press release)
A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to immunotherapy.

Continue reading

2017-08-07 Michael Zand NEWS

CRISPR Screen Identifies Top 100 Essential Genes for Cancer Immunotherapy – Genetic Engineering & Biotechnology News


EurekAlert (press release)

NCI study identifies essential genes for cancer immunotherapy
EurekAlert (press release)
A new study identifies genes that are necessary in cancer cells for immunotherapy to work, addressing the problem of why some tumors don’t respond to immunotherapy or respond initially but then stop as tumor cells develop resistance to immunotherapy.

Continue reading

2017-08-07 Michael Zand NEWS

MilliporeSigma to Be Granted European Patent for CRISPR Technology – Genetic Engineering & Biotechnology News


Genetic Engineering & Biotechnology News

CRISPR Screen Identifies Top 100 Essential Genes for Cancer Immunotherapy
Genetic Engineering & Biotechnology News
To try to understand the genetic basis of these differing responses, scientists at the U.S. National Institutes of Health developed a genome-scale CRISPR/Cas9 screen that allowed them to knock out every single gene in a melanoma cell line and then …

and more »

Continue reading

2017-08-07 Michael Zand NEWS
  • 1
  • …
  • 1,389
  • 1,390
  • 1,391
  • 1,392
  • 1,393
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

MilliporeSigma to Be Granted European Patent for CRISPR Technology
Genetic Engineering & Biotechnology News
The European Patent Office has told MIlliporeSigma it intends to grant approval of its patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells—the second key patent awarded in Europe …